THE USE OF KRATOM IN AMERICA
Kratom is a food supplement that has been used for centuries in Southeast Asia to help alleviate discomfort and tension. It was first introduced into America after The Vietnam War by returning soldiers, but only recently did its popularity start growing mainstream- currently an estimated 5 million people use this supplement because its an inexpensive option that sells between nine dollars per ounce on the internet. According to the Botanical Education Alliance, in 2022 the industry could be worth as much as $1.13 billion dollars.
Kratom is a plant that people use to relieve the symptoms of opioid withdrawal and treat discomfort. It’s also been reported as an energizing supplement, able to give you mood boosts when needed for those days where everything just seems so heavy! The average age range for users falls between 18 – 40 years old with men making up the majority of most groups using this type of herbal supplement.
The most recent data varies, showing in some cases high numbers of people that have being admitted to hospitals for Kratom exposure, while an even larger number of hospital admissions show on the blood toxicology of the patients a high number of other substances and illicit drugs present as well which makes it hard to determine the cause. The numbers, depending on where they are sourced show 32% resulted in an admission and 52 percent had serious medical outcomes such as seizure or respiratory distress! The one aspect that must be noted is that Kratom does not suppress the respiratory system, which means, in cases of respiratory distress there is likely another cause such as shown in the blood toxicology reports.
KRATOM REGULATION AT THE FEDERAL AND STATE LEVEL
It’s no secret that Kratom has managed to cause great controversy in America. The Federal government and organizations are at odds about the potential dangers (or lack thereof) of using this plant-based supplement while some states have banned or proposed a ban on its sale entirely; however, there is still more work left for scientists who want answers before they make sweeping conclusions based off limited data sets!
ATTEMPTS AT REGULATING KRATOM IN THE U.S.
In the mid-1990s when smoke shops first began stocking Kratom products, some store operators attempted to boost sales of this natural wonder drug by mixing it with other drugs like heroin and morphine. Eventually adverse events caused from these mixed drinks prompted a U.S Drug Enforcement Administration warning about 2005 that stated “This influx in popularity has also led many vendors selling krypton.” In 2009 nine people died Sweden over 12 months after consuming “Krypton” which contained Tramadol at toxic levels.
In 2012, the FDA issued an import alert on Kratom which was further augmented by two more seizures totaling over $5 million in California during September 2014. In January 2016 authorities seized around 90 thousand bottles of dietary supplements containing this herb and then again just last summer we saw over 100 cases captured at different locations nationwide making waves once more! Don’t let these events get you down; instead reach out today so that our team can help protect your rights as well.
Despite harsh backlash, the DEA pulled their scheduling notice on October 14th and instead opened up a public comment period. Over 23 thousand submissions were received against this ban which accounted for 99% of all opposition in those two weeks time frame! The FDA failed to meet an expedited deadline so as result it was dropped by both agencies–the move which saved us from negotiating yet another unnecessary war with Big Pharma over something that doesn’t even belong there anyway.
THE FDA’S RECENT POSITIONS AND ACTIONS TOWARDS KRATOM
In October 2017, the FDA renewed its interest in scheduling its two psychoactive compounds and submitted an 8-factor analysis to the DEA. A month later they announced a public health advisory on this drug claiming that it was associated with 36 deaths but has similar effects as opioids which can lead you into addiction or put your life at risk if taken incorrectly. They also mention how there is currently no easy way for consumers who want access outside of pill form due demanding requirements set forth by law so we should keep our eyes peeled!
The 3-D computer model of its chemical makeup can reveal how it might behave inside the body, and what effect that has on your brain. Based on this data from PHASE (a program used to simulate interactions), researchers were able not only determine if these compounds are opioids but also labels them as such by their structure–and therefore potential side effects too!
According to the AKA, there are many similarities between Kratom and caffeine. For example: both substances have similar pharmacological effects; they can be smelled or tasted in your mouth after consumption (although this isn’t always true for caffeine samples). But unlike most other drugs on our list – which may lead you down an addiction path with devastating consequences Kratom only produces mild psychological dependence if any at all. AKA also emphasizes how few deaths connected directly back their product seem likely due not just because people take supplements containing MORE than one ingredient sometimes.
The AKA does not support the FDA’s proposal to regulate Kratom because it is opposed to any regulations that would increase costs for consumers. The group also objects when their mission–to protect people from adulterated products-is conflated with other issues, such as age restrictions on purchasing or using this natural supplement In addition they feel there should be no change in what information needs go onto labels if selling materializes outside North America where youth have been shown interest despite legally being adults at 18 years old.
The AKA’s good manufacturing practices (GMP) standards program is designed to increase the safety of kratom products. To be eligible for this initiative, manufacturers must commit themselves and pass strict inspection criteria annually with pre-approval from an independent auditor who has been Certified Fraud Examiner (CE). The goal here in conjunction with our partners at FDA & USDA? Staggering social harms caused by prescription medication abuse combined alongside unprecedented levels…
THE AMERICAN KRATOM ASSOCIATION’S POSITION
The American Kratom Association is a Virginia-based nonprofit corporation that strives to protect the rights of Americans as they use this product. They were established in 2014 and have gone on record saying how opposed they are towards any attempts at scheduling or controlling its availability, stating their belief that it has only potential for abuse if consumed recreationally which would make them just another Schedule I drug alongside heroin; something we don’t want here!
The Good Manufacturing Qualification Program (GMP) is a qualification requirement for companies wanting to sell products in the European Union. The $500 initial registration fee and 1K annual re-certification are necessary costs that must be paid when applying, but there’s more! You also need standard operating procedures with proper record keeping; an adverse event reporting system including truthful marketing practices; plus compliance programs implemented by all vendors who want acceptance into this prestigious program– currently 12 out 16 applicants meet these criteria so far…
KRATOM LAWS ON THE LOCAL AND STATE LEVELS
Kratom is currently illegal in six states and the District of Columbia, but not all Kratom sellers are aware that their product can be controlled by regulating agencies. Some local governments have implemented regulatory controls on this drug to ban its sale or possession within city limits– Alabama, Arkansas, Indiana, Rhode Island, Vermont Wisconsin, Washington D C .
The AKA is encouraging states to stop short of a total ban by developing model legislation that would allow dealers of the drug verify their products and prevent them from being distributed or sold if they are adulterated or contaminated with something other than what’s advertised. Additionally, these bills prohibit people under 18 years old from purchasing it as well–a step in preventing young consumers becoming addicted which has become increasingly common due recent events involving powerful drugs such cannabis flowers containing THC at high concentrations levels greater than 20 ppm (parts per million).
The Model proposes that violations of these provisions would result in a misdemeanor punishable by imprisonment for not more than 90 days or fine up to $500 dollars, and maybe both.
The Kratom Consumer Protection Act was passed in four states this year, but there’s still more work to be done. Four more than last time! The sad news is that three of those are places where you can’t buy or use Kratom at all– Tennessee (21), Minnesota(18) and Illinois(17). But we’re not giving up hope just yet because our organization has been working hard on behalf of consumers across America while fighting against laws criminalizing them altogether.”
- Laurie McGinley and Katie Zezima, “Kratom is hailed as a natural pain remedy, assailed as an addictive killer. The U.S.
- wants to treat it like heroin,” Washington Post, February 10, 2018
- Ike Swetlitz, “HHS recommended that DEA make kratom a Schedule I drug, like LSD or heroin,” Stat, November 9, 2018
- Jacqueline Stenson, “What is kratom? The popular herbal supplement has caught flak from the FDA,” NBC News, October
- 16, 2019
- Joey Garrison, “Poison reports related to herbal drug kratom soar, new study says,” USA Today, February 24, 2019
- “Kratom Fact Sheet,” American Kratom Association, January 2019
- Megan Jula, “Kratom users say it’s a miracle drug. The feds say it’s dangerous.,” Mother Jones, May 30, 2018
- “FDA and Kratom,” Food and Drug Administration, last modified September 11, 2019
- Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA advisory about deadly risks associated with kratom,”
- Food and Drug Administration, November 14, 2017
- Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s scientific evidence on the presence of opioid
- compounds in kratom, underscoring its potential for abuse,” Food and Drug Administration, February 6
- “Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner for Foods and Veterinary
- Medicine Stephen Ostroff, M.D., on the ongoing risk of salmonella in kratom products,” Food and Drug Administration,
- July 2, 2018
- “Laboratory analysis of kratom products for heavy metals,” Food and Drug Administration, last modified April 3, 2019
- “FDA issues warnings to companies selling illegal, unapproved kratom drug products marketed for opioid cessation, pain
- treatment and other medical uses,” Food and Drug Administration, June 25, 2019
- “Legal,” American Kratom Association, accessed October 21, 2019
- Jack E. Henningfield, Reginald V. Fant, Daniel W. Wang, “The abuse potential of kratom according the 8 factors of the
- controlled substances act: implications for regulation and research,” Psychopharmacology, 235 (December 2017): 575
- Jane Babin, “FDA Fails to Follow the Sciences on Kratom,” American Kratom Association, August 2018, 13
- “Statement of Principles,” American Kratom Association, accessed on October 21, 2019
- “AKA Good Manufacturing Practice (GMP) Standards Program,” American Kratom Association, accessed October 21,
- “State-by-state Kratom Developments,” American Kratom Association, accessed October 21, 2019
- “Rhode Island Schedules Kratom,” Speciosa, accessed October 21, 2019
- “Is kratom legal where I live?,” Kraken Kratom, January 15, 2019
- “AKA Advocacy Toolkit,” American Kratom Association, accessed October 21, 2019